Profil
John Nicholas Lambert is the founder of Cryptopharma Pty Ltd. founded in 2000.
He worked as a Chief Executive Officer, Director & MD at Amplia Therapeutics Ltd. from 2020 to 2022.
He was a Principal Director-Product Development Operations at Biota Holdings Pty Ltd. from 2011 to 2013.
He worked as a Research Director-US Operations at Biota, Inc. He was a Senior Director at Medicines Development for Global Health Ltd from 2016 to 2020.
He also worked as a Senior Lecturer at the University of Melbourne and as a Vice President-Product Development & Operations at Aviragen Therapeutics, Inc. Dr. Lambert holds a doctorate degree from the University of Melbourne.
Ehemalige bekannte Positionen von John Nicholas Lambert
| Unternehmen | Position | Ende |
|---|---|---|
| AMPLIA THERAPEUTICS LIMITED | Vorstandsvorsitzender | 05.12.2022 |
Medicines Development for Global Health Ltd
Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Develops medicines and vaccines | Direktor/Vorstandsmitglied | 01.09.2020 |
Cryptopharma Pty Ltd.
Cryptopharma Pty Ltd. Medical SpecialtiesHealth Technology Develops novel anti-inflammatory therapeutic agents for treatment of pulmonary diseases | Gründer | 04.05.2011 |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Geschäftsführer | - |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von John Nicholas Lambert
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Biota Holdings Pty Ltd.
Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as an anti infective drug development company | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cryptopharma Pty Ltd.
Cryptopharma Pty Ltd. Medical SpecialtiesHealth Technology Develops novel anti-inflammatory therapeutic agents for treatment of pulmonary diseases | Health Technology |
Biota, Inc. | |
Medicines Development for Global Health Ltd
Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Develops medicines and vaccines | Health Technology |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Health Technology |
Amplia Therapeutics Ltd.
Amplia Therapeutics Ltd. BiotechnologyHealth Technology Develops drug candidates for oncology and chronic fibrosis | Health Technology |
















